Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.056
Companies that carry out R&D in Biotechnology	Main	551
Companies that carry out R&D in Biotechnology	Secondary dwellings	183
Companies that carry out R&D in Biotechnology	Tool	323
%Companies according to biotechnology used: Genetic code	Total	36
%Companies according to biotechnology used: Genetic code	Main	46
%Companies according to biotechnology used: Genetic code	Secondary dwellings	22
%Companies according to biotechnology used: Genetic code	Tool	26
%Companies according to biotechnology used: Functional units	Total	45
%Companies according to biotechnology used: Functional units	Main	51
%Companies according to biotechnology used: Functional units	Secondary dwellings	38
%Companies according to biotechnology used: Functional units	Tool	38
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	27
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	33
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	21
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	21
%Companies according to biotechnology used: Bioprocesses	Total	47
%Companies according to biotechnology used: Bioprocesses	Main	41
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	48
%Companies according to biotechnology used: Bioprocesses	Tool	55
%Companies according to biotechnology used: Sub-cellular organisms	Total	8
%Companies according to biotechnology used: Sub-cellular organisms	Main	12
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	8
%Companies according to biotechnology used: Sub-cellular organisms	Tool	4
%Companies according to biotechnology used: Bio-computing	Total	25
%Companies according to biotechnology used: Bio-computing	Main	33
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	13
%Companies according to biotechnology used: Bio-computing	Tool	17
%Companies according to biotechnology used: Nanobiotechnology	Total	13
%Companies according to biotechnology used: Nanobiotechnology	Main	18
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	12
%Companies according to biotechnology used: Nanobiotechnology	Tool	5
%Companies according to biotechnology used: Other	Total	15
%Companies according to biotechnology used: Other	Main	16
%Companies according to biotechnology used: Other	Secondary dwellings	16
%Companies according to biotechnology used: Other	Tool	13
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	49
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	65
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	38
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	27
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	20
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	25
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	19
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	13
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	30
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	23
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	31
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	42
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	23
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	20
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	24
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	26
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	13
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	11
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	25
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	11
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	12
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	13
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	19
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	7
Personnel in R&D in biotechnology (no. of persons)	Total	10.719
Personnel in R&D in biotechnology (no. of persons)	Main	5.901
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.572
Personnel in R&D in biotechnology (no. of persons)	Tool	3.245
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	6.131
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	3.640
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	912
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	1.579
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	4.588
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	2.261
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	661
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	1.667
Personnel in R&D in biotechnology (no. of persons): women	Total	6.040
Personnel in R&D in biotechnology (no. of persons): women	Main	3.443
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	844
Personnel in R&D in biotechnology (no. of persons): women	Tool	1.753
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	3.411
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	2.087
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	511
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	812
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	2.629
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	1.356
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	333
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	941
Personnel in R&D in biotechnology (FTE)	Total	7.751
Personnel in R&D in biotechnology (FTE)	Main	4.659,2
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	980,5
Personnel in R&D in biotechnology (FTE)	Tool	2.111,1
Personnel in R&D in biotechnology (FTE): Researchers	Total	4.518,1
Personnel in R&D in biotechnology (FTE): Researchers	Main	2.855,6
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	621
Personnel in R&D in biotechnology (FTE): Researchers	Tool	1.041,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	3.232,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	1.803,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	359,5
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	1.069,6
Personnel in R&D in biotechnology (FTE): women	Total	4.471,4
Personnel in R&D in biotechnology (FTE): women	Main	2.697,8
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	549,7
Personnel in R&D in biotechnology (FTE): women	Tool	1.223,9
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	2.562,7
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	1.637,8
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	360,6
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	564,3
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	1.908,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	1.060
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	189,1
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	659,6
Internal expenditure on R&D (thousands of euros)	Total	679.558
Internal expenditure on R&D (thousands of euros)	Main	446.123
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	82.011
Internal expenditure on R&D (thousands of euros)	Tool	151.424
1) By nature of the expense: Current expenses	Total	634.631
1) By nature of the expense: Current expenses	Main	412.211
1) By nature of the expense: Current expenses	Secondary dwellings	78.386
1) By nature of the expense: Current expenses	Tool	144.035
1.1) Remuneration to researchers	Total	228.857
1.1) Remuneration to researchers	Main	153.206
1.1) Remuneration to researchers	Secondary dwellings	31.881
1.1) Remuneration to researchers	Tool	43.769
1.2) Remuneration to technicians and assistants	Total	104.498
1.2) Remuneration to technicians and assistants	Main	61.567
1.2) Remuneration to technicians and assistants	Secondary dwellings	12.726
1.2) Remuneration to technicians and assistants	Tool	30.205
1.3) Other current expenses	Total	301.276
1.3) Other current expenses	Main	197.437
1.3) Other current expenses	Secondary dwellings	33.779
1.3) Other current expenses	Tool	70.060
2) By nature of the expense: Capital expenses	Total	44.927
2) By nature of the expense: Capital expenses	Main	33.912
2) By nature of the expense: Capital expenses	Secondary dwellings	3.625
2) By nature of the expense: Capital expenses	Tool	7.389
2.1) Land and buildings	Total	2.585
2.1) Land and buildings	Main	2.159
2.1) Land and buildings	Secondary dwellings	90
2.1) Land and buildings	Tool	337
2.2) Equipment and instruments	Total	23.569
2.2) Equipment and instruments	Main	14.228
2.2) Equipment and instruments	Secondary dwellings	3.239
2.2) Equipment and instruments	Tool	6.101
2.3) Acquisition of specific R+D software	Total	1.392
2.3) Acquisition of specific R+D software	Main	709
2.3) Acquisition of specific R+D software	Secondary dwellings	128
2.3) Acquisition of specific R+D software	Tool	555
2.4) Otros productos de propiedad intelectual específicos para I+D	Total	17.381
2.4) Otros productos de propiedad intelectual específicos para I+D	Main	16.817
2.4) Otros productos de propiedad intelectual específicos para I+D	Secondary dwellings	168
2.4) Otros productos de propiedad intelectual específicos para I+D	Tool	396
1) By origin of the funds: National funds	Total	556.297
1) By origin of the funds: National funds	Main	336.896
1) By origin of the funds: National funds	Secondary dwellings	71.496
1) By origin of the funds: National funds	Tool	147.904
1.1) Own funds	Total	387.010
1.1) Own funds	Main	240.941
1.1) Own funds	Secondary dwellings	42.317
1.1) Own funds	Tool	103.752
1.2) From companies	Total	86.025
1.2) From companies	Main	41.093
1.2) From companies	Secondary dwellings	17.175
1.2) From companies	Tool	27.757
1.3) Public Administration funds	Total	74.764
1.3) Public Administration funds	Main	49.704
1.3) Public Administration funds	Secondary dwellings	11.115
1.3) Public Administration funds	Tool	13.944
1.4) From Universities	Total	408
1.4) From Universities	Main	340
1.4) From Universities	Secondary dwellings	2
1.4) From Universities	Tool	66
1.5) From non profit private institutions	Total	8.090
1.5) From non profit private institutions	Main	4.818
1.5) From non profit private institutions	Secondary dwellings	887
1.5) From non profit private institutions	Tool	2.385
1) By origin of the funds: Foreign funds	Total	123.262
1) By origin of the funds: Foreign funds	Main	109.227
1) By origin of the funds: Foreign funds	Secondary dwellings	10.514
1) By origin of the funds: Foreign funds	Tool	3.520
2.1) From EU programmes	Total	25.125
2.1) From EU programmes	Main	14.287
2.1) From EU programmes	Secondary dwellings	7.967
2.1) From EU programmes	Tool	2.871
2.2) Other foreign funds	Total	98.137
2.2) Other foreign funds	Main	94.940
2.2) Other foreign funds	Secondary dwellings	2.547
2.2) Other foreign funds	Tool	649
Purchase of R&D services in biotechnology (thousands of euros)	Total	147.558
Purchase of R&D services in biotechnology (thousands of euros)	Main	104.940
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	19.473
Purchase of R&D services in biotechnology (thousands of euros)	Tool	23.146
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	76.875
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	54.648
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	12.216
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	10.011
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	70.683
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	50.292
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	7.256
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	13.135
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	49
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	59
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	45
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	32
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	11
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	20
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	25
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	17
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	13
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	21
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	10
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	24
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	19
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	11
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Total	17
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Main	16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Secondary dwellings	21
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Tool	16
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	40
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	39
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	33
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	51
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	56
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	52
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	44
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	18
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	17
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	22
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	18
% Companies that have requested biotechnology patents	Total	16
% Companies that have requested biotechnology patents	Main	23
% Companies that have requested biotechnology patents	Secondary dwellings	9
% Companies that have requested biotechnology patents	Tool	6
Number of patents requested	Total	746
Number of patents requested	Main	539
Number of patents requested	Secondary dwellings	142
Number of patents requested	Tool	65
% Companies with income of an international origin related to biotechnological activities	Total	23,3
% Companies with income of an international origin related to biotechnological activities	Main	33,8
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	11,6
% Companies with income of an international origin related to biotechnological activities	Tool	12
% Turnover representing income of an international origin related to biotechnological activities	Total	1,2
% Turnover representing income of an international origin related to biotechnological activities	Main	14,5
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	0
% Turnover representing income of an international origin related to biotechnological activities	Tool	0,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	60,4
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	66,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	74,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	24,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	39,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	33,4
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	25,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	75,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	80,9
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	78
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	70,6
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	98,2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	17,8
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	21,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	0,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	1,3
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	1,3
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	0,6
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	29
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	0,6
% Income of an international origin related with activities according to the classification: Other	Total	0,1
% Income of an international origin related with activities according to the classification: Other	Main	0,1
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0
% Income of an international origin related with activities according to the classification: Other	Tool	0